MediWound Launches Clinical Development Program for Treatment of Non-Melanoma Skin Cancer

Go back to MediWound Launches Clinical Development Program for Treatment of Non-Melanoma Skin Cancer
MEDIWOUND (NASDAQ: MDWD) Delayed: 4.47 +0.57 (14.62%)
Previous Close $3.90    52 Week High $10.47 
Open $3.90    52 Week Low $5.10 
Day High $4.47    P/E N/A 
Day Low $3.85    EPS $0.00 
Volume 258,470